Novartis’ Ritalin LA Faces Patent Challenge
This article was originally published in The Pink Sheet Daily
Executive Summary
Patents relate to controlled-release dosing forms.
You may also be interested in...
Teva Generic Versions Of Focalin Clear FDA With 180-Day Exclusivity
The approval includes 2.5 mg, 5 mg and 10 mg formulations of dexmethylphenidate tabs for ADHD.
Teva Generic Versions Of Focalin Clear FDA With 180-Day Exclusivity
The approval includes 2.5 mg, 5 mg and 10 mg formulations of dexmethylphenidate tabs for ADHD.
GSK Dexedrine Adds Black Box On Cardiovascular Events
ADHD product also adds class warnings on psychiatric events, seizures and visual disturbance.